Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-24-006599
Filing Date
2024-11-26
Accepted
2024-11-26 16:15:17
Documents
77
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_112624.htm   iXBRL 6-K 13926
2 EXHIBIT 99.1 exh_991.htm   iXBRL EX-99.1 691389
3 EXHIBIT 99.2 exh_992.htm EX-99.2 313140
4 GRAPHIC novelpipeline.jpg GRAPHIC 27363
5 GRAPHIC engagerplatform.jpg GRAPHIC 38321
6 GRAPHIC singleagentactivity.jpg GRAPHIC 50555
  Complete submission text file 0001171843-24-006599.txt   4463864

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE ptgef-20240930.xsd EX-101.SCH 65908
8 XBRL CALCULATION FILE ptgef-20240930_cal.xml EX-101.CAL 53110
9 XBRL DEFINITION FILE ptgef-20240930_def.xml EX-101.DEF 134441
10 XBRL LABEL FILE ptgef-20240930_lab.xml EX-101.LAB 265376
11 XBRL PRESENTATION FILE ptgef-20240930_pre.xml EX-101.PRE 245489
79 EXTRACTED XBRL INSTANCE DOCUMENT f6k_112624_htm.xml XML 616183
Mailing Address CLARENCE THOMAS BUILDING P.O. BOX 4649, ROAD TOWN TORTOLA D8 VG1110
Business Address CLARENCE THOMAS BUILDING P.O. BOX 4649, ROAD TOWN TORTOLA D8 VG1110 416-737-7600
PORTAGE BIOTECH INC. (Filer) CIK: 0001095435 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40086 | Film No.: 241503967
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)